comparemela.com
Latest Breaking News On - Investigation medicinal product - Page 1 : comparemela.com
Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: December 2022 Quarterly Activities and Cash Flow
Investegate announcements from MGC Pharmaceuticals, December 2022 Quarterly Activities and Cash Flow
Malta
Australia
Licenza
Lazio
Italy
United-states
Denmark
United-kingdom
Brazil
Slovenia
Portugal
Ireland
MGC Pharmaceuticals Ltd shares rise after preliminary results indicate wide-ranging application of CimetrA as an anti-inflammatory treatment
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has received preliminary results from a pre-clinical in-vitro study of CimetrA, indicating that it has.
Israel
Israeli
Roby-zomer
Mgc-pharmaceuticals-ltd
Investigation-medicinal-product
Human-peripheral-blood-mononuclear-cells
Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: CimetrATM Pre-clinical Trial Progress Report
Investegate announcements from MGC Pharmaceuticals, CimetrATM Pre-clinical Trial Progress Report
United-kingdom
Australia
United-states
Ireland
Israel
Tavistock
Devon
Brazil
America
Israeli
Turner-pope
Roby-zomer
vimarsana © 2020. All Rights Reserved.